Corteria Pharmaceuticals is based in Paris, France. It has raised $71M in total funding. Latest round: Series A.
Corteria Pharmaceuticals is based in Paris, France. Corteria Pharmaceuticals has raised $71M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2023. The round record for Corteria Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include OrbiMed, Jeito Capital, Kurma Partners, Fountain Healthcare Partners, V-Bio Ventures, Invivo Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Totals shown for Corteria Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Paris and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026